“A new global response to drugs is essential, one grounded in science, health, compassion and human rights”
In May, Denver voters approved a ballot measure to decriminalize psilocybin mushrooms.
Shortly after Denver decriminalized psilocybin, Oakland followed the lead and extended the legislation to all naturally-occurring psychedelics.
Following a wave of support for psilocybin decriminalization, we partnered with Decriminalized California, to decriminalize psilocybin in the state of California and introduce legislation which allows research and medical access to psilocybin.
In support of the growing body of evidence showing the efficacy of MDMA-assisted psychotherapy for PTSD, we published a report ‘Roadmaps to Regulation: MDMA’ outlining a 3 stage process of drug policy reform to reschedule, decriminalize, and regulate MDMA.
In November, the House Judiciary Committee made history with the first-ever congressional vote on federally legalizing cannabis.
In June, Illinois became the 11th US state to legalize adult-use cannabis.
In September, the Australian Capital Territory became the first jurisdiction in Australia to legalize possession of up to 50g of marijuana and 2 plants.
In April, Israel decriminalized possession of the cannabis plant and its buds. In public spaces, individuals found to be carrying small amounts of cannabis without medical authorization will now face fines rather than be subjected to criminal proceedings.
During the last U.K general election, the major political parties all addressed the need for drug policy reform, and the need for a health care centered approach. Finally after 50 years, we are accepting that the War on Drugs has failed.
In 2019, 3 U.S states decriminalized cannabis possession: New Mexico, Hawaii, and North Dakota.
Psilocybin for Depression
Type of publication